Isolation of high density lipoprotein subclasses by electrofiltration and their chemical components

Preparative Biochemistry and Biotechnology

Volumn 39, Issue 3, 2009, Pages 248-265

  Atmeh, Ragheb F ^a   Kana'an, Belal M ^a   Massad, Tariq T ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

ApoA I Albumin lipoprotein; Electroelution; Electrofiltration; Electroimmunoblotting; Electrophoresis; HDL lipids; HDL subclasses isolation

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ARTICLE; CLASSIFICATION; ELECTROCHEMISTRY; FILTRATION; ISOLATION AND PURIFICATION; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; THIN LAYER CHROMATOGRAPHY;

CHROMATOGRAPHY, THIN LAYER; ELECTROCHEMISTRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FILTRATION; LIPOPROTEINS, HDL;

EID: 68049118733     PISSN: 10826068     EISSN: 15322297     Source Type: Journal    
DOI: 10.1080/10826060902952964     Document Type: Article

References (59)

1. Barter, P.J.; Nicholls, S.; Rye, K.A.; Anantharamaiah, G.M.; Navab, M.; Fogelman, A.N. Anti-inflammatory properties of HDL. Circ. Res. 2004, 95, 764-772.
2. Navab, M.; Ananthramaiah, G.M.; Reddy, S.T.; Van Lenten, B.J.; Ansell, B.J.; Fogelman, A.M. Mechanisms of disease: Proatherogenic HDL an evolving field. Nat. Clin. Pract. Endocrinol. Metab. 2006, 2, 504-511.
3. Reilly, M.P.; Tall, A.R. HDL proteomics: Pot of gold or Pandora's box? J. Clin. Invest. 2007, 117, 595-598.
4. Suenram, A.; McConathy, W.J.; Alaupovic, P. Evidence for the lipoprotein heterogeneity of human plasma HDL isolated by three different procedures. Lipids 1979, 14, 505-510.
5. Castro, G.R.; Fielding, C.J. Early incorporation of cell-derived cholesterol into pre-b-migrating high density lipoprotein. Biochemistry 1988, 27, 25-29.
6. Braschi, S.; Neville, T.A.-M.; Vohl, M-C.; Sparks, D.L. Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo. J. Lipid Res. 1999, 40, 522-532.
7. Kontush, A.; Chapman, J. Functionally defective high density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 2006, 58, 342-347.
8. Tall, A.R. CETP inhibitors to increase HDL levels. N. Engl. J. Med. 2007, 356, 1364-1366.
9. Ansell, B.J.; Navab, M.; Hama, S. Inflammatory=anti-inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favourably affected by simvastatin treatment. Circulation 2003, 108, 2751-2756.
10. Ansell, B.J.; Watson, K.E.; Fogelman, A.M.; Navab, M.; Fonarow, G.C. High density lipoprotein function. J. Am. Coll. Cardiol. 2005, 46, 1792-1798.
11. Milochevitch, C.; Khalil, A. Study of the paraoxonase and platelet activating factor acetylhydrolase activities with aging. Prostaglandins Leukot. Essent. Fatty Acids 2001, 65, 241-246.
12. Seres, I.; Paragh, G.; Deschene, E.; Fulop, Jr., T.; Khalil, A. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp. Gerontol. 2004, 39, 59-66.
13. Sun, Y.; Yang, Y.; Pei, W.; Wu, Y.; Zhao, J. Is elevated high density lipoprotein cholesterol always good for coronary heart disease? Clin. Cardiol. 2007, 30, 576-580.
14. Phillips, J.C.; Wriggers, W.; Li, Z.; Jonas, A.; Schulten, K. Prediction of the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks. Biophys. J. 1997, 73, 2337-2346.
15. Lindgren, F.T.; Elliott, H.A.; Gofman, J.W. The ultracentrifugal characterization and isolation of human blood lipids and lipoproteins, with applications to the study of atherosclerosis. J. Phys. Colloid Chem. 1951, 55, 80-93.
16. Delalla, O.F.; Gofman, J.W. Ultrtacentrifugal analysis of serum lipoproteins. In Methods of biochemical analysis; Glick, D.; Ed.; Interscience Publishers: New York, 1954; Vol. 1, 459.
17. Havel, R.J.; Eder, H.A.; Bragdon, J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34, 1345-1353.
18. Tall, A.R.; Blum, C.B.; Forester, G.P.; Nelson, C.A. Changes in the distribution and composition of plasma high density lipoproteins after ingestion of fat. J. Biol. Chem. 1982, 257, 198-207.
19. Kontush, A.; Chantepie, S.; Chapman, M.J. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1881-1888.
20. Anderson, D.W.; Nichols, A.V.; Forte, T.M.; Lindgren, F.T. Particle distribution of human serum high density lipoproteins. Biochim. Biophys. Acta 1977, 493, 55-68.
21. Blanche, P.J.; Gong, E.L.; Forte, T.; Nichols, A.V. Characterization of human high density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta 1981, 665, 408-419.
22. Verdery, R.B.; Benham, D.F.; Baldwin, H.L.; Goldberg, A.P.; Nicols, A.V. Measurement of normative HDL subfraction cholesterol levels by Gaussian summation analysis of gradient gels. J. Lipid Res. 1989, 30, 1085-1095.
23. Li, Z.; McNamara, J.R.; Ordovas, J.M.; Schaefer, E.J. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J. Lipid Res. 1994, 35, 1698-1711.
24. Vézina, C.A.; Milne, R.W.; Weech, P.K.; Marcel, Y.L. Apolipoprotein distribution in human lipoproteins separated by polyacrylamide gradient gel electrophoresis. J. Lipid Res. 1988, 29, 573-585.
25. Freedman, D.S.; Otvos, J.D.; Jeyarajah, E.J.; Barboriak, J.J.; Anderson, A.J.; Walker, J.A. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 4046-4053.
26. Duverger, N.; Rader, D.; Duchateau, P.; Fruchart, J.C.; Castro, G.; Brewer, H.B. Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma. Biochemistry 1993, 32, 12372-12379.
27. Nanjee, M.N.; Brinton, E.A. Very small apolipoprotein A-I-containing particles from human plasma: Isolation and quantification by highperformance size-exclusion chromatography. Clin. Chem. 2000, 46, 207-223.
28. Atmeh, R.F.; Shepherd, J.; Packard, C.J. Subpopulations of apolipoprotein A-I in human high-density lipoproteins, their metabolic properties and response to drug therapy. Biochim. Biophys. Acta 1983, 751, 175-188.
29. Cheung, M.C.; Albers, J.J. Characterization of lipoprotein particles isolated by immuno-affinity chromatography, particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 1984, 259, 12201-12209.
30. Atmeh, R.F.; Abuharfeil, N. Electroblotting of proteins on agarose gel containing specific antibodies. Electrophoresis 1983, 14, 69-72.
31. Atmeh, R.F.; Robenek, H. Measurement of small high density lipoprotein subclass by improved immunoblotting technique. J. Lipid Res. 1996, 37, 2461-2469.
32. Asztalos, B.F.; Sloop, C.H.; Wong, L.; Roheim, P.S. Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apoA-I-containing subpopulations. Biochim. Biophys. Acta 1993, 1169, 291-300.
33. Atmeh, R.F. Isolation and identification of HDL particles of low molecular weight. J. Lipid Res. 1990, 31, 1771-1780.
34. Reschly, E.J.; Sorci-Thomas, M.G.; Davidson, W.S.; Meredith, S.C.; Reardon, C.A., Getz, G.S. Apolipoprotein A-I a-helices 7 and 8 modulate high density lipoprotein subclass distribution. J. Biol. Chem. 2002, 277, 9645-9654.
35. Maiorano, J.N.; Jandacek, R.J.; Horace, E.M.; Davidson, W.S. Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size. Biochemistry 2004, 43, 11717-11726.
36. Atmeh, R.F.; Issa, A.E.O. Small high density lipoprotein subclasses: Some of their physico-chemical properties. Acta Biochim. Pol. 2005, 52, 515-525.
37. Atmeh, R.F.; Massad, T.T.; Kana'an, B.M.; Abu-Alrob, A.A. Separation of biomacromolecules by electrofiltration through gel layers. Anal. Biochem. 2008, 373, 307-312.
38. Atmeh, R.F. Concentration of dilute solutions of macromolecules by electrophoresis. Anal. Biochem. 1989, 182, 315-318.
39. Atmeh, R.F.; Abu-Harfeil, N.M.; El-Sukhon, S.N.; Abu-Shehada, M.N. Electrophoretic elution of macromolecules from polyacrylamide or agarose gels. Prep. Biochem. 1991, 21, 1-9.
40. Skipski, V.P.; Barclay, M.; Barclay, R.K.; Fetzer, V.A.; Good, J.J.; Archibald, F.M. Lipid composition of human serum lipoproteins. Biochem. J. 1967, 104, 340-352.
41. Converse, C.A.; Skinner, E. Lipoprotein analysis a practical approach; Oxford University Press: New York, 1992; 215.
42. Skipski, V.P.; Peterson, R.F.; Barclay, M. Thin layer chromatography of phospholipids using silica gel without calcium sulfate binder. J. Lipid Res. 1963, 4, 227-228.
43. Willer, C.J.; Sanna, S.; Jackson, A.U. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nature Genet. 2008, 40, 161-169.
44. Van Acker, B.A.C.; Botma, G.-J.; Zwinderman, A.H.; Kuivenhoven, J.A.; Dallinga-Thie, G.M.; Sijbrands, E.J.G.; Boer, J.M.A.; Seidell, J.C.; Jukema, J.W.; Kastelein, J.J.P.; Jansen, H.; Verhoeven, A.J.M. And for the REGRESS Study Group. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants. doi:10.1016=j.atherosclerosis. 2007.11.019.
45. Catalano, G.; Duchene, E.; Julia, Z., Le Goff, W.; Bruckert, E.; Chapman, M.J.; Guerin, M. Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender specific in healthy subjects. J. Lipid Res. 2008, 49, 635-643.
46. Leroy, A.; Harms Toohill, K.L.; Fruchart, J-C.; Jonas, A. Structural properties of high density lipoprotein subclasses homogeneous in protein composition and size. J. Biol Chem. 1993, 268, 4798-4805.
47. van der Steeg, W.A.; Hovingh, G.K.; Klerkx, A.H.E.M.; Hutten, B.A.; Nootenboom, I.C.; Levels, J.H.M.; van Tol, A.; Dallinga-Thie, G.M.; Zwinderman, A.H.; Kastelein, J.J.P.; Kuivenhoven, J.A. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians. J. Lipid Res. 2007, 48, 674-682.
48. Boekholdt, S.M.; Souverein, O.W.; Tanck, M.W.; Hovingh, G.K.; Kuivenhoven, J.A.; Peters, R.I.; Jansen, H.; Schiffers, P.M.; van der Wall, E.E.; Doevendans, P.A. Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels. Clin. Genet. 2006, 69, 263-270.
49. Fogelman, A.M. When good cholesterol goes bad. Nat. Med. 2004, 10, 902-903.
50. Vasan, R.S. Biomarkers of cardiovascular disease, molecular basis and practical considerations. Circulation 2006, 113, 2335-2362.
51. Chétiveaux, M.; Nazih, H.; Ferchaud-Roucher, V.; Lambert, G.; Zaïr, Y., Masson, M.; Ouguerram, K.; Bouhours, D.; Krempf, M. The differential apoA-I enrichment of prebeta1 and alpha-HDL is detectable by gel filtration separation. J. Lipid Res. 2002, 43, 1986-1993.
52. Jaspard, B.; Collet, X.; Barbaras, R.; Manent, J.; Vieu, C.; Parinaud, J.; Chap, H.; Perre, B. Biochemical characterization of pre-b1-HDL from human ovarian follicular fluid: Evidence for the presence of a lipid core. Biochemistry 1996, 35, 1352-1357.
53. Ohta, T.; Hattori, S.; Nishiyama, S.; Matsuda, I. Studies on the lipid and apolipoprotein compositions of two species of apoA-I-containing lipoproteins in normolipidemic males and females. J. Lipid Res. 1988, 29, 721-728.
54. Atmeh, R.F.; Shabsoug, B. Detection and semiquantitation of albumin forms in fresh human plasma separated on gradient polyacrylamide gel by means of electroblotting on agarose gel matrix. Electrophoresis 1997, 18, 2055-2058.
55. Wille, L.E.; Torsvik, H.; Gjone, E. Studies on the pre-alpha-lipoprotein in patients with familial lecithin:cholesterol acyltransferase deficiency. Clin. Chim. Acta 1997, 77, 423-429.
56. Wille, L.E.; Torsvik, H.; Kierulf, P.; Gjone, E. Studies on the pre-alphalipoprotein of human serum. II. Evidence for the presence of an albuminapo-A-I-complex. Scnd. J. Clin. Lab. Invest. 1977, 37, 545-549.
57. Demacker, P.N.; Jansen, R.T.; Hijmans, A.G.; van Gorp, H.P. A case of hyperalphalipoproteinemia associated with albumin complexing. Atherosclerosis 1994, 111, 13-23.
58. Maugeais, C.; Braschi, S.; Ouguerram, K.; Maugeais, P.; Mahot, P.; Jacotot, B.; Darmau, D.; Magot, T.; Krempf, M. Lipoprotein kinetics in patients with analbuminemia, evidence for the role of serum albumin in controlling lipoprotein metabolism. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 1369-1375.
59. Zhao, Y.; Marcel, Y.L. Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins. Biochemistry 1996, 35, 7174-7180.